These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7904655)

  • 1. Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity.
    Pawagi AB; Wang J; Silverman M; Reithmeier RA; Deber CM
    J Mol Biol; 1994 Jan; 235(2):554-64. PubMed ID: 7904655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
    Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
    Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism.
    Zhang M; Wang G; Shapiro A; Zhang JT
    Biochemistry; 1996 Jul; 35(30):9728-36. PubMed ID: 8703944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport.
    Dwyer DS
    Proteins; 2001 Mar; 42(4):531-41. PubMed ID: 11170207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
    Shen X; Chen G; Zhu G; Fong WF
    Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
    Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
    Chen Y; Pant AC; Simon SM
    Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.
    Taguchi Y; Kino K; Morishima M; Komano T; Kane SE; Ueda K
    Biochemistry; 1997 Jul; 36(29):8883-9. PubMed ID: 9220975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of multidrug transporter substrates within model membranes.
    Siarheyeva A; Lopez JJ; Glaubitz C
    Biochemistry; 2006 May; 45(19):6203-11. PubMed ID: 16681393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of mitochondrial carriers - role of the transmembrane helix P and G residues in the gating and transport mechanism.
    Palmieri F; Pierri CL
    FEBS Lett; 2010 May; 584(9):1931-9. PubMed ID: 19861126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: evidence for half-of-the-sites reactivity.
    Wang EJ; Casciano CN; Clement RP; Johnson WW
    Arch Biochem Biophys; 2000 Nov; 383(1):91-8. PubMed ID: 11097180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).
    Ambudkar SV; Kim IW; Sauna ZE
    Eur J Pharm Sci; 2006 Apr; 27(5):392-400. PubMed ID: 16352426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.
    Jedlitschky G; Leier I; Buchholz U; Center M; Keppler D
    Cancer Res; 1994 Sep; 54(18):4833-6. PubMed ID: 7915193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane orientation of transmembrane segments 11 and 12 of MDR- and non-MDR-associated P-glycoproteins.
    Zhang JT; Ling V
    Biochim Biophys Acta; 1993 Dec; 1153(2):191-202. PubMed ID: 7903865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors.
    Eckford PD; Sharom FJ
    Biochem Cell Biol; 2006 Dec; 84(6):1022-33. PubMed ID: 17215888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
    Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
    Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.